Skip to content

Research into epilepsy: Differences in brain activity caused by visual stimuli.

Epilepsy Identification Using Biomarkers based on Visually Evoked EEG Responses. - EPI-BIOVERSE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57570
Enrollment
80
Registered
2024-11-19
Start date
2026-01-16
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, epileptic seizures, PNES, unexplained seizures Epilepsy

Interventions

The intervention consists of the visual stimulation during the EEG recording.&nbsp
This consists of three different modalities: a stroboscopic flash lamp with&nbsp
flashes between 1 and 60 Hz, as standard in the clinic
LED goggles with chirp&nbsp
and a screen with alternating red-blue stimulation with varying&nbsp
modulation depth and vertical stripes, with and without color. This will last about half an hour. This is no therapeutic intervention, only&nbsp
the direct response to the stimulation in the EEG will be evauated and&nbsp
compared.

Sponsors

Stichting Epilepsie Instellingen Nederland (SEIN)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Controls must: - Be over 18 years - Have sufficient proficiency in Dutch or English EMU patients must: - Be over 18 years - Have sufficient proficiency in Dutch or English - Meet the ILAE criteria for epilepsy, diagnosed by trained neurologists.

Exclusion criteria

Exclusion criteria: Healthy controls must not - Have previously been diagnosed with epilepsy (e.g. childhood epilepsy) - Have previously been diagnosed with PNES - Have a 1st-degree family member with epilepsy - Have a neurological (intracranial/CNS) condition that likely influences  cortical excitability  - Have a neurological (intracranial/CNS) condition that is severe enough to  take neuroactive medication for EMU participants must not  - Have no diagnosis of epilepsy - Have any neurological (intracranial/CNS) condition other than epilepsy or  PNES that likely influences cortical excitability  - Have any neurological (intracranial/CNS) condition other than epilepsy that  is severe enough to take neuroactive medication for All participants must not  - Have any condition which prevents them from sitting still for 30 minutes - Have any condition which prevents them from concentrating for 30 minutes - Have any history of problems or conditions involving eyesight (excluding  pre-scription lenses or glasses) - Have any psychiatric disorder - Be unable to sign their own consent form (no legal representative) - Be pregnant

Design outcomes

Primary

MeasureTime frame
The classification performance of the machine learning model using biomarkers analysed in EEG-responses during various types of visual stimulation to distinguish between people with epilepsy and healthy participants. This will be assessed based on sensitivity, specificity, accuracy, and the area under the ROC curve (AUROC).

Secondary

MeasureTime frame
The classification performance of a machine learning model using these biomarkers to distinguish focal epilepsy from generalised epilepsy will be assessed based on sensitivity, specificity, accuracy, and the area under the ROC curve (AUROC). The classification performance of a machine learning model using these biomarkers to distinguish PNES from healthy individuals will be assessed based on sensitivity, specificity, accuracy, and the area under the ROC curve (AUROC). Identification of the most important EEG biomarkers contributing to model classification of people with or without epilepsy will be done by extracting them from the model.

Countries

Netherlands

Contacts

Public ContactR.M. Helling

Stichting Epilepsie Instellingen Nederland (SEIN)

rhelling@sein.nl023 - 558 8963

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 14, 2026